Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/30/2013CN102379873B Acute general Parkinson's disease monkey model and medicament screening method thereof
10/30/2013CN102378627B Antibacterial composition comprising 4 -isopropyl-3-methylpheno and zinc ions
10/30/2013CN102351784B Benidipine hydrochloride crystal form and application thereof
10/30/2013CN102344440B Anticoccidial compound for livestock and poultry and preparation method thereof
10/30/2013CN102336764B Spin-labeling rotenone oxime ester, its preparation method and application
10/30/2013CN102276593B Heterocyclic ketene hydrazone compound and preparation method as well as tubercle bacillus resistant application
10/30/2013CN102276554B 4-((2-amino-5-sulfydryl-1,3,4-thiadiazole)-methyl)-benzamide derivative as well as preparation method and application thereof
10/30/2013CN102274160B Method and preparation for treating resistance to antihypertensives and related conditions
10/30/2013CN102268005B Indole diketopiperazine alkaloid compound derived from tryptophan and proline and preparation method and application thereof
10/30/2013CN102260274B Preparation method and application of anticancer compound
10/30/2013CN102250105B Camptothecin derivatives, synthesis method thereof and use thereof
10/30/2013CN102247342B Application of alkyl isourea compound
10/30/2013CN102240290B Pharmaceutical composition containing prulifloxacin, and preparation method thereof
10/30/2013CN102239164B 2H-chromene compound and derivative thereof
10/30/2013CN102225896B Ether derivatives of rhein and their therapeutic use
10/30/2013CN102219745B 2-aryl substituted benzimidazole derivatives, as well as preparation method and application thereof
10/30/2013CN102199121B 4-(4-(3-trifluoro methyl) benzamido phenoxyl)-2-(methyl carbamyl) pyridine salt, its preparation method and application
10/30/2013CN102188693B Proteoglycan complex
10/30/2013CN102159223B Treating or preventing rotavirus infection
10/30/2013CN102153504B Method for preparing 1-deoxynojirimycin in mulberry leaves
10/30/2013CN102108078B 1,4-substituted phthalazine compound and preparation method and applications thereof
10/30/2013CN102099344B Imidazole carboxamides
10/30/2013CN102078322B Medical purpose of piperacillin sodium and tazobactam sodium for injection
10/30/2013CN102066360B Quinoline or isoquinoline substituted P2X7 antagonists
10/30/2013CN102036667B Compositions comprising quinazoline derivatives, preparation methods and uses thereof
10/30/2013CN102018711B Application of chelerythrine in preparing medicine for killing aquatic animal ectoparasites and preventer
10/30/2013CN101959890B Pyrrolopyrimidinecarboxamides
10/30/2013CN101951923B Liquid nucleotides/nucleosides-containing product
10/30/2013CN101945662B Nutraceutical composition and methods of use
10/30/2013CN101919858B Solid pharmaceutical dosage form
10/30/2013CN101906056B Cycloalkane amine compound as M2 inhibitor and application thereof
10/30/2013CN101885684B Aromatic acid pro-drug with nitrogen monoxide donor, and preparation method and application thereof
10/30/2013CN101855221B Pyridazinone derivatives as PARP inhibitors
10/30/2013CN101835770B Condensed compounds with activity at estrogen receptors
10/30/2013CN101821259B Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in field of blood coagulation
10/30/2013CN101810638B Preparation method of endogenous interferon inducer injection and nanometer microencapsulation solution
10/30/2013CN101786953B Kaurane-type diterpenoid compound as well as preparation method and medical application thereof
10/30/2013CN101780075B Combined drug for treating insomnia
10/30/2013CN101768202B Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof
10/30/2013CN101768149B Beta- aminoketone (alkamine) derivatives and use thereof
10/30/2013CN101677942B Intravesical apaziquone administration following transurethral resection for treating cancer
10/30/2013CN101676286B Azaindoles useful as inhibitors of JAK and other protein kinases
10/30/2013CN101668423B 2-aminopyrimidine modulators of histamine h4 receptor
10/30/2013CN101652346B Indole derivatives, methods for preparing same, and use thereof particularly as antibacterial agents
10/30/2013CN101605457B P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-ss-d-ribofuranosyl)-3h-thiazole [4, 5-d] pyrimidine-2-one and methods for preparation
10/30/2013CN101591230B 2,4-dyhydroxyl chalcone derivative, preparation method and application thereof
10/30/2013CN101578266B Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
10/30/2013CN101550185B Tumor-related gene or protein and application thereof
10/30/2013CN101535307B Triazole derivatives as kinase inhibitors
10/30/2013CN101528712B Substituted benzimidazolone derivatives, medicaments comprising them and their use
10/30/2013CN101511805B Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
10/30/2013CN101506180B Human protein tyrosine phosphatase inhibitors and methods of use
10/30/2013CN101503414B Thiazolo[3,2-b]-1,2,4-triazine derivative and use thereof
10/30/2013CN101484212B Carotenoid compositions useful for whitening skin
10/30/2013CN101472476B Treating obesity with muscarinic receptor M1 antagonists
10/30/2013CN101432275B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/30/2013CN101429183B 2H-1-benzopyran-2-ketone compounds with alpha-glucosidase inhibit activity, its composition and preparation method thereof
10/30/2013CN101426783B Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/30/2013CN101415464B Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them
10/30/2013CN101257946B Pharmaceutical dosage form containing active principle combination of nifedipine and/or nisoldipine and of angiotensin II antagonist
10/30/2013CN101247834B Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
10/30/2013CN101084215B Piperidine and azetidine derivatives as GLYT1 inhibitors
10/30/2013CN101023066B Substituted triazines as prion protein ligands and their use to detect or remove prions
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569542 Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
10/29/2013US8569536 C-nitroso-derived nitroxyl donors
10/29/2013US8569522 6-substituted phenoxychroman carboxylic acid derivatives
10/29/2013US8569511 Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase
10/29/2013US8569509 Thiazole-4-carboxylic acid esters and thioesters as plant protection agents
10/29/2013US8569507 N-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for the identification of biological and pharmacological activity
10/29/2013US8569504 Imidazopyridine compound
10/29/2013US8569502 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
10/29/2013US8569495 Anthelmintic agents and their use
10/29/2013US8569480 Hydroxyethylstarch
10/29/2013US8569479 Process for reducing the average molecular weight of cellulose ethers
10/29/2013US8569466 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
10/29/2013US8569385 Hydrolysis resistant organomodified silylated ionic surfactants
10/29/2013US8569383 Utilization of rhinologically active substances
10/29/2013US8569382 Isolated compounds from Phaleria macrocarpa as anti-cancer agents
10/29/2013US8569381 Combination therapy for the management of hypertension
10/29/2013US8569380 Oligomer-tricyclic conjugates
10/29/2013US8569379 Use of rasagiline for the treatment of olfactory dysfunction
10/29/2013US8569378 p27 protein inducer
10/29/2013US8569377 Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel
10/29/2013US8569376 Methods and compositions for reducing body fat and adipocytes
10/29/2013US8569375 Compositions
10/29/2013US8569374 NADPH oxidase inhibition pharmacotherapies for obstructive sleep apnea syndrome and its associated morbidities
10/29/2013US8569373 Compositions comprising A C2-C14 carboxylic acid and a surfactant for treating hoof diseases
10/29/2013US8569372 Method for preventing or treating a disease, disorder or condition induced by retina ischemia
10/29/2013US8569371 Crystal forms of O-desmethylvenlafaxine fumarate
10/29/2013US8569370 Ophthalmic compositions and methods for treating eyes
10/29/2013US8569369 Amino acid compounds
10/29/2013US8569368 Amino acid compounds
10/29/2013US8569367 Ophthalmic compositions and methods for treating eyes
10/29/2013US8569366 Acetyl L-carnitine for prevention of painful peripheral neuropathy in patients with type 2 diabetes
10/29/2013US8569364 5-substituted benzofurans as inhibitors of cytochrome P450 2D6
10/29/2013US8569363 Antimicrobial and radioprotective compounds
10/29/2013US8569362 Polyketide molecules as anticancer agents
10/29/2013US8569361 Aliphatic amino acid biosynthesis inhibitors and a method of synthesizing the same
10/29/2013US8569360 Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling
1 ... 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 ... 7860